FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Müller

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Psychomotor Performance

Geographic Areas

Germany

Procedures

Physiology

Co-author Network

Publications

TOP 3
Thomas Bein; Jörg Brederlau; Rolf Dembinski; Anton Goldmann; Bernhard M Graf; Matthias Lubnow; Ralf M Muellenbach; Thomas Müller; Alois Philipp; Thomas Staudinger; Steffen Weber-Carstens; Klaus-Dieter Wernecke; Marlene Wewalka; Arthur S Slutsky
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS : The prospective randomized Xtravent-study.
Florian Kraus; Thomas Müller; Monalisa Panda; Barbara Albert
closo-Hydroborates from Liquid Ammonia: Synthesis and Crystal Structures of [Li(NH3)4]2[B12H12]·2NH3, Rb2[B12H12]·8NH3, Cs2[B12H12]·6NH3 and Rb2[B10H10]·5NH3.
S Skodda; Thomas Müller
Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa® therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Müller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Bein; Jörg Brederlau; Rolf Dembinski; Anton Goldmann; Bernhard M Graf; Matthias Lubnow; Ralf M Muellenbach; Thomas Müller; Alois Philipp; Thomas Staudinger; Steffen Weber-Carstens; Klaus-Dieter Wernecke; Marlene Wewalka; Arthur S Slutsky
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS : The prospective randomized Xtravent-study.
Intensive care medicine 2013;39(5):847-56.
2013: Florian Kraus; Thomas Müller; Monalisa Panda; Barbara Albert
closo-Hydroborates from Liquid Ammonia: Synthesis and Crystal Structures of [Li(NH3)4]2[B12H12]·2NH3, Rb2[B12H12]·8NH3, Cs2[B12H12]·6NH3 and Rb2[B10H10]·5NH3.
Inorganic chemistry 2013;52(8):4692-9.
2013: S Skodda; Thomas Müller
Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa® therapy.
Journal of neural transmission (Vienna, Austria : 1996) 2013;120(2):315-8.
2013: Thomas Müller; Angela Pietsch
Comparison of gait training versus cranial osteopathy in patients with Parkinson's disease: a pilot study.
NeuroRehabilitation 2013;32(1):135-40.
2012: Daniele Camboni; Bernhard Flörchinger; Assad Haneya; Michael Hilker; Andreas Keyser; Reinhard Kobuch; Matthias Lubnow; Dirk Lunz; Alois Philipp; Leopold Rupprecht; Christof Schmid; Simon Schopka; York A Zausig; Thomas Bein; Thomas Müller
Extracorporeal membrane oxygenation by single-vessel access in adults: advantages and limitations.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2012;58(6):616-21.
2012: Assad Haneya; Michael Hilker; Stephan Hirt; Matthias Lubnow; Andreas Luchner; Alois Philipp; Christof Schmid; Simon Schopka; Markus Zimmermann; Ayman Agha; Thomas Bein; Claudius Diez; Thomas Müller
A 5-year experience with cardiopulmonary resuscitation using extracorporeal life support in non-postcardiotomy patients with cardiac arrest.
Resuscitation 2012;83(11):1331-7.
2012: Thomas Müller; Siegfried Muhlack
Cysteine decrease following acute Levodopa intake in patients with Parkinson's disease.
Neuroscience letters 2012;521(1):37-9.
2012: Thomas Müller; Thomas Haas; Sven Lütge; Marion Marg; Reinhard Ehret
Trichophagia affects response to duodenal levodopa/carbidopa gel administration.
Movement disorders : official journal of the Movement Disorder Society 2012;27(4):588-90.
2012: Thomas Müller; Manfred Gerlach; Moussa B H Youdim; Peter Riederer
Psychiatric, nonmotor aspects of Parkinson's disease.
Handbook of clinical neurology 2012;106():477-90.
2011: Dierk Endemann; Christian Hengstenberg; Michael Hilker; Andreas Luchner; Thomas Müller; Alois Philipp; Thomas Pühler; Günter A J Riegger; Christof Schmid; Markus Resch
A simple method of vascular access to perform emergency coronary angiography in patients with veno-arterial extracorporeal membrane oxygenation.
Intensive care medicine 2011;37(12):2046-9.
2011: Daniele Camboni; Claudius Diez; Assad Haneya; Matthias Lubnow; Alois Philipp; Christof Schmid; Thomas Bein; Thomas Müller
Support time-dependent outcome analysis for veno-venous extracorporeal membrane oxygenation.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2011;40(6):1341-6;discussion 1346-7.
2011: Thomas Müller; Siegfried Muhlack; Gunar Bengel; Georg Ebersbach; Reinhard Ehret; Constanze Jugel; Fabian Klostermann
Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(9):1329-33.
2011: Thomas Müller; Dirk Woitalla; Siegfried Muhlack
Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease.
Naunyn-Schmiedeberg's archives of pharmacology 2011;383(6):627-33.
2011: Alois Philipp; Matthias Amann; Matthias Arlt; Bernhard Graf; Michael Hilker; Dirk Lunz; Thomas Müller; Christof Schmid
First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport.
Interactive cardiovascular and thoracic surgery 2011;12(6):978-81.
2011: Angela Baljuls; Regina Mahr; Inge Schwarzenau; Thomas Müller; Lisa Polzien; Mirko Hekman; Ulf R Rapp
Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase.
The Journal of biological chemistry 2011;286(18):16491-503.
2011: Sieglinde Kofler; Christine Wolf; Natalija Shvets; Zeljka Sisic; Thomas Müller; Jürgen Behr; Hae-Young Sohn; Michael Vogeser; Maria Shipkova; Bruno Meiser; Gerhard Steinbeck; Bruno Reichart; Ingo Kaczmarek
The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2011;30(5):565-71.
2011: Thomas Müller; Matthias Lubnow; Alois Philipp; Wulf Schneider-Brachert; Daniele Camboni; Christof Schmid; Karla Lehle
Risk of circuit infection in septic patients on extracorporeal membrane oxygenation: a preliminary study.
Artificial organs 2011;35(4):E84-90.
2011: Thomas Müller; Siegfried Muhlack
Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2011;26(3):543-6.
2011: Jan M Vetter; Lars Frisch; Christian Drosten; R Stefan Ross; Michael Roggendorf; Bernd Wolters; Thomas Müller; H Burkhard Dick; Norbert Pfeiffer
Survival after transplantation of corneas from a rabies-infected donor.
Cornea 2011;30(2):241-4.
2011: Rita Willemssen; Michael Falkenstein; Michael Schwarz; Thomas Müller; Christian Beste
Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
Neurobiology of aging 2011;32(2):327-35.
2010: Edna Grünblatt; Sonja Zehetmayer; Christian P Jacob; Thomas Müller; Wolfgang H Jost; Peter Riederer
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(12):1387-93.
2010: Thomas Müller; Siegfried Muhlack
Acute homocysteine rise after repeated levodopa application in patients with Parkinson's disease.
Parkinsonism & related disorders 2010;16(10):688-9.
2010: Thomas Müller; D Woitalla
Quality of life, caregiver burden and insurance in patients with Parkinson's disease in Germany.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(11):1365-9.
2010: Matthias Lubnow; Andreas Luchner; Alois Philipp; Stefan Buchner; Andreas Jeron; Christian Karagiannidis; Thomas Bein; Michael Pawlik; Carsten Jungbauer; Christof Schmid; Günter A J Riegger; Michael Pfeifer; Thomas Müller
Combination of high frequency oscillatory ventilation and interventional lung assist in severe acute respiratory distress syndrome.
Journal of critical care 2010;25(3):436-44.
2010: Svetlana Hamm; Eicke Latz; Doris Hangel; Thomas Müller; Philipp Yu; Douglas Golenbock; Tim D. Sparwasser; Hermann Wagner; Stefan Bauer
Alternating 2'-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist.
Immunobiology 2010;215(7):559-69.
2010: Dunkel Marcel; Thomas Müller; Rainer Hedrich; Dietmar Geiger
K+ transport characteristics of the plasma membrane tandem-pore channel TPK4 and pore chimeras with its vacuolar homologs.
FEBS letters 2010;584(11):2433-9.
2010: Stefan Buchner; Kurt Debl; Stefan Barlage; Daniel Griese; Sabine Fredersdorf; Andreas Jeron; Matthias Lubnow; Thomas Müller; Frank Muders; Stephan Holmer; Günter A J Riegger; Andreas Luchner
Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(6):875-81.
2010: Thomas Müller; Ali Harati
Diadochokinetic movements differ between patients with Parkinson's disease and controls.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(2):189-95.
2009: Sieglinde Kofler; Amir K Bigdeli; Ingo Kaczmarek; Diana Kellerer; Thomas Müller; Michael Schmoeckel; Gerhard Steinbeck; Peter Uberfuhr; Bruno Reichart; Bruno Meiser
Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center.
Transplant international : official journal of the European Society for Organ Transplantation 2009;22(12):1140-50.
2009: Volker Spindler; Wolfgang-Moritz Heupel; Athina Efthymiadis; Enno Schmidt; Rüdiger Eming; Christian Rankl; Peter Hinterdorfer; Thomas Müller; Detlev Drenckhahn; Jens Waschke
Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus.
The Journal of biological chemistry 2009;284(44):30556-64.
2009: Thomas Müller; Siegfried Muhlack
Peripheral COMT inhibition prevents levodopa associated homocysteine increase.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(10):1253-6.
2009: Matthias Arlt; Alois Philipp; Markus Zimmermann; Sabine Voelkel; Matthias Amann; Thomas Bein; Thomas Müller; Maik Foltan; Christof Schmid; Bernhard Graf; Michael Hilker
Emergency use of extracorporeal membrane oxygenation in cardiopulmonary failure.
Artificial organs 2009;33(9):696-703.
2009: Thomas Müller
Role of intraspinal steroid application in patients with multiple sclerosis.
Expert review of neurotherapeutics 2009;9(9):1279-87.
2009: Thomas Müller; Wilfried Kuhn
Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(9):1339-43.
2009: Thomas Müller; Wilfried Kuhn
Cysteine elevation in levodopa-treated patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(6):929-32.
2009: S Siebig; S Kuhls; U Gather; M Imhoff; Thomas Müller; Thomas Bein; Benedikt Trabold; S Bele; Christian E Wrede
[Noise in intensive care units. Do the alarms for subspecialties differ].
Der Anaesthesist 2009;58(3):240-2, 244-6.
2009: Markus Resch; Günter A J Riegger; Thomas Schichtl; Wulf Schneider-Brachert; Kathrin Tintelnot; Simone Bertz; Christoph Birner; Christina Hart; Michael Hilker; Clemens Jilek; Katrin Kurz; Matthias Lubnow; Andreas Luchner; Thomas Müller
Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany.
BMJ case reports 2009;2009():.
2009: Thomas Müller
Possible treatment concepts for the levodopa-related hyperhomocysteinemia.
Cardiovascular psychiatry and neurology 2009;2009():969752.
2009: Thomas Müller; Alois Philipp; Andreas Luchner; Christian Karagiannidis; Thomas Bein; Michael Hilker; Leopold Rupprecht; Julia Langgartner; Markus Zimmermann; Matthias Arlt; Jan Wenger; Christof Schmid; Günter Aj Riegger; Michael Pfeifer; Matthias Lubnow
A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure.
Critical care (London, England) 2009;13(6):R205.
2009: Thomas Müller
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.
Patient preference and adherence 2009;3():51-9.
2009: Stefan Bauer; Thomas Müller; Svetlana Hamm
Pattern recognition by Toll-like receptors.
Advances in experimental medicine and biology 2009;653():15-34.
2009: Rita Willemssen; Thomas Müller; Michael Schwarz; Michael Falkenstein; Christian Beste
Response monitoring in de novo patients with Parkinson's disease.
PloS one 2009;4(3):e4898.
2009: Kerstin Hellwig; Sebastian Schimrigk; Christian Beste; Thomas Müller; Ralf Gold
Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis.
European neurology 2009;61(2):65-8.
2008: Marcel Dunkel; Andreas Latz; Karin Schumacher; Thomas Müller; Dirk Becker; Rainer Hedrich
Targeting of vacuolar membrane localized members of the TPK channel family.
Molecular plant 2008;1(6):938-49.
2008: Karla Lehle; Alois Philipp; Otto Gleich; Andreas Holzamer; Thomas Müller; Thomas Bein; Christof Schmid
Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2008;54(6):612-7.
2008: Bernhard Flörchinger; Alois Philipp; Alexander Klose; Michael Hilker; Reinhard Kobuch; Leopold Rupprecht; Andreas Keyser; Thomas Pühler; Stephan Hirt; Karsten Wiebe; Thomas Müller; Julia Langgartner; Karla Lehle; Christof Schmid
Pumpless extracorporeal lung assist: a 10-year institutional experience.
The Annals of thoracic surgery 2008;86(2):410-7; discussion 417.
2008: Claudia Wahl; Sabine Kautzmann; Guido Krebiehl; Karsten Strauss; Dirk Woitalla; Thomas Müller; Peter Bauer; Olaf Riess; Rejko Krüger
A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patients.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(8):1141-8.
2008: Thomas Müller; Dirk Woitalla; Oliver Goetze; Christoph Erdmann
Entacapone improves absorption of a coadministered salt in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(10):1458-61.
2008: Kerstin Hellwig; Nils Brune; Arash Haghikia; Thomas Müller; Sebastian Schimrigk; V Schwödiauer; Ralf Gold
Reproductive counselling, treatment and course of pregnancy in 73 German MS patients.
Acta neurologica Scandinavica 2008;118(1):24-8.
2008: Thomas Müller
Role of homocysteine in the treatment of Parkinson's disease.
Expert review of neurotherapeutics 2008;8(6):957-67.
2008: Thomas Müller; Siegfried Muhlack
Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):851-5.
2008: Thomas Müller; Kira Kolf; Lema Ander; Dirk Woitalla; Siegfried Muhlack
Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease.
Clinical neuropharmacology 2008;31(3):134-40.
2008: Kerstin Hellwig; Sebastian Schimrigk; Malte Fischer; Arash Haghikia; Thomas Müller; Andrew Chan; Ralf Gold
Allergic and nonallergic delayed infusion reactions during natalizumab therapy.
Archives of neurology 2008;65(5):656-8.
2008: Thomas Müller; Horst Przuntek; Meike Rieks; Anita Mackowiak
Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells.
Neurological research 2008;30(4):417-9.
2008: Christopher G Goetz; Eugene Laska; Christine Hicking; Philippe Damier; Thomas Müller; John G Nutt; C Warren Olanow; Olivier Rascol; Hermann Russ
Placebo influences on dyskinesia in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):700-7.
2008: Kerstin Hellwig; Christian Beste; Niels Brune; Arash Haghikia; Thomas Müller; Sebastian Schimrigk; Ralf Gold
Increased MS relapse rate during assisted reproduction technique.
Journal of neurology 2008;255(4):592-3.
2008: C Trenkwalder; S Boesch; A Ceballos-Baumann; D Dressler; K Eggert; T Gasser; H Honig; Thomas Müller; Heinz Reichmann; J P Sieb; A Storch; P Odin; Werner Poewe
[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].
Der Nervenarzt 2008;79(4):475-9.
2008: Thomas Bein; Thomas Müller; S Weber-Carstens
[Extracorporeal lung support procedures (ECMO/iLA)].
Pneumologie (Stuttgart, Germany) 2008;62(3):137-42.
2008: Gisa Ellrichmann; Ali Harati; Thomas Müller
Deep brain stimulation improves performance of complex instrumental paradigms.
European neurology 2008;60(1):32-6.
2008: R Willemssen; Thomas Müller; M Schwarz; J Hohnsbein; Michael Falkenstein
Error processing in patients with Parkinson's disease: the influence of medication state.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(3):461-8.
2008: Birgit Meiler; Jürgen Andrich; Thomas Müller
Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.
Movement disorders : official journal of the Movement Disorder Society 2008;23(1):145-6.
2007: Peter Riederer; Manfred Gerlach; Thomas Müller; Heinz Reichmann
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
Parkinsonism & related disorders 2007;13(8):466-79.
2007: Thomas Müller; Jacub Welnic; Dirk Woitalla; Siegfried Muhlack
Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
Neuroscience letters 2007;422(2):119-22.
2007: Alois Philipp; Thomas Müller; Thomas Bein; Maik Foltan; Franz X Schmid; Dietrich Birnbaum; Christof Schmid
Inhibition of thrombocyte aggregation during extracorporeal lung assist: a case report.
Perfusion 2007;22(4):293-7.
2007: Alexander Storch; Wolfgang H Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Archives of neurology 2007;64(7):938-44.
2007: G Ellrichmann; Hermann Russ; Thomas Müller
[Dyskinesia in Parkinson's disease--major clinical features, aetiology, therapy].
Fortschritte der Neurologie-Psychiatrie 2007;75(7):387-96.
2007: Thomas Müller; Wilfried Kuhn
Neurotoxicity of levodopa: treatment-associated homocysteine increase.
Nature clinical practice. Neurology 2007;3(6):E1.
2007: Thomas Müller; Christoph Erdmann; Siegfried Muhlack; Dirk Bremen; Horst Przuntek; Dirk Woitalla
Entacapone improves complex movement performance in patients with Parkinson's disease.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2007;14(5):424-8.
2007: Jürgen Andrich; Carsten Saft; Natalie Ostholt; Thomas Müller
Complex movement behaviour and progression of Huntington's disease.
Neuroscience letters 2007;416(3):272-4.
2007: Thomas Müller
Rivastigmine in the treatment of patients with Alzheimer's disease.
Neuropsychiatric disease and treatment 2007;3(2):211-8.
2007: Jürgen Andrich; Carsten Saft; Natalie Ostholt; Thomas Müller
Assessment of simple movements and progression of Huntington's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(4):405-7.
2007: Thomas Müller; Siegfried Muhlack
Acute levodopa intake and associated cortisol decrease in patients with Parkinson disease.
Clinical neuropharmacology 2007;30(2):101-6.
2007: Thomas Müller; Jacub Welnic; Siegfried Muhlack
Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(3):347-50.
2007: Siegfried Muhlack; Jacub Welnic; Dirk Woitalla; Thomas Müller
Exercise improves efficacy of levodopa in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(3):427-30.
2007: Christopher G Goetz; Philippe Damier; Christine Hicking; Eugene Laska; Thomas Müller; C Warren Olanow; Olivier Rascol; Hermann Russ
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):179-86.
2007: Christian Beste; Carsten Saft; Jürgen Andrich; Thomas Müller; Ralf Gold; Michael Falkenstein
Time processing in Huntington's disease: a group-control study.
PloS one 2007;2(12):e1263.
2007: Susanne Walitza; Siebke Melfsen; G Herhaus; Peter Scheuerpflug; Andreas Warnke; Thomas Müller; Klaus W Lange; Manfred Gerlach
Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.
Journal of neural transmission. Supplementum 2007;(72):311-5.
2007: Thomas Müller; L Ander; K Kolf; Dirk Woitalla; Siegfried Muhlack
Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(11):1457-62.
2007: Thomas Müller; Dirk Woitalla; Hermann Russ; K Hock; Doris-Anita Haeger
Prevalence and treatment strategies of dyskinesia in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(8):1023-6.
2006: Thomas Franck; R Krueger; Dirk Woitalla; Thomas Müller; Simone Engelender; Olaf Riess
Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(12):1903-8.
2006: Robert A Hauser; Hermann Russ; Doris-Anita Haeger; Michel Bruguiere-Fontenille; Thomas Müller; Gregor Wenning
Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
Clinical neuropharmacology 2006;29(6):322-30.
2006: Siegfried Muhlack; Wimar Lemmer; Peter Klotz; Thomas Müller; Erlo Lehmann; Eckhard Klieser
Anxiolytic effect of rescue remedy for psychiatric patients: a double-blind, placebo-controlled, randomized trial.
Journal of clinical psychopharmacology 2006;26(5):541-2.
2006: Thomas Müller; Christoph Erdmann; Siegfried Muhlack; Dirk Bremen; Horst Przuntek; Oliver Goetze; Dirk Woitalla
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(10):1441-8.
2006: Kerstin Hellwig; Sebastian Schimrigk; Carsten Lukas; Volker Hoffmann; Nils Brune; Horst Przuntek; Thomas Müller
Efficacy of mitoxantrone and intrathecal triamcinolone acetonide treatment in chronic progressive multiple sclerosis patients.
Clinical neuropharmacology 2006;29(5):286-91.
2006: Thomas Müller; Hermann Russ
Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.
Expert opinion on pharmacotherapy 2006;7(13):1715-30.
2006: Dirk Woitalla; Oliver Goetze; Jeong I Kim; Alice B Nikodem; Wolfgang E Schmidt; Horst Przuntek; Thomas Müller
Levodopa availability improves with progression of Parkinson's disease.
Journal of neurology 2006;253(9):1221-6.
2006: Thomas Müller; Gerd Fuchs; Matthias Hahne; Wolfgang Klein; Michael Schwarz
Diagnostic aspects of early Parkinson's disease.
Journal of neurology 2006;253 Suppl 4():IV29-31.
2006: Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller
Assessment of simple movements reflects impairment in Huntington's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(8):1208-12.
2006: Thomas Müller; Wilfried Kuhn
Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients.
European journal of clinical pharmacology 2006;62(6):447-50.
2006: Thomas Müller; Christoph Erdmann; Dirk Bremen; Wolfgang E Schmidt; Siegfried Muhlack; Dirk Woitalla; Oliver Goetze
Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.
Clinical neuropharmacology 2006;29(2):61-7.
2006: Thomas Müller; Christoph Erdmann; Siegfried Muhlack; Dirk Bremen; Horst Przuntek; Dirk Woitalla
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.
Movement disorders : official journal of the Movement Disorder Society 2006;21(3):332-6.
2006: Thomas Müller; Jacub Welnic; G Fuchs; H Baas; G Ebersbach; Heinz Reichmann
The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
Journal of neural transmission. Supplementum 2006;(71):27-30.
2006: Thomas Müller; Richard Dodel; Jürgen Fritze
[Cost and quality aspects in the treatment of Parkinson's disease].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2006;100(4):291-5.
2006: Kerstin Hellwig; Carsten Lukas; Nils Brune; Sebastian Schimrigk; Horst Przuntek; Thomas Müller
Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis.
TheScientificWorldJournal 2006;6():460-5.
2006: Siegfried Muhlack; Horst Przuntek; Thomas Müller
Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease.
Pharmacopsychiatry 2006;39(1):16-9.
2006: Volker Hoffmann; Wilfried Kuhn; Sebastian Schimrigk; Saida Islamova; Kerstin Hellwig; Carsten Lukas; Nils Brune; Dieter Pöhlau; Horst Przuntek; Thomas Müller
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(1):72-6.
2006: Anna Melissa Schlitter; M Kurz; Jan Petter Larsen; Dirk Woitalla; Thomas Müller; Jörg T Epplen; Gabriele Dekomien
Parkin gene variations in late-onset Parkinson's disease: comparison between Norwegian and German cohorts.
Acta neurologica Scandinavica 2006;113(1):9-13.
2005: Thomas Müller; Brian Fowler; Wilfried Kuhn
Levodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson disease.
Clinical neuropharmacology 2005;28(6):274-6.
2005: Thomas Müller; Undine E Lang; Siegfried Muhlack; Jacub Welnic; Rainer Hellweg
Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson disease.
Clinical neuropharmacology 2005;28(5):238-40.
2005: Daniela Berg; Marc Niwar; Sylvia Maass; Alexander Zimprich; J Carsten Möller; Ullrich Wüllner; Tanja Schmitz-Hübsch; Christine Klein; Eng-King Tan; Ludger Schöls; Laura Marsh; Ted M Dawson; Bernd Janetzky; Thomas Müller; Dirk Woitalla; Vladimir Kostic; Peter P Pramstaller; Wolfgang H Oertel; Peter Bauer; Rejko Krueger; Thomas Gasser; Olaf Riess
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1191-4.
2005: Karsten M Strauss; L Miguel Martins; Helene Plun-Favreau; Frank P Marx; Sabine Kautzmann; Daniela Berg; Thomas Gasser; Zbigniew K Wszolek; Thomas Müller; Antje Bornemann; Hartwig Wolburg; Julian Downward; Olaf Riess; Jörg B Schulz; Rejko Krüger
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
Human molecular genetics 2005;14(15):2099-111.
2005: Carsten Saft; Jürgen Andrich; Thomas Müller; H Przuntek; Markus Stücker
[Segmental dysfunction of sweating in multiple system atrophy].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2005;56(8):773-6.
2005: Thomas Müller; Wilfried Kuhn; Horst Przuntek
Efficacy of budipine and placebo in untreated patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(8):1015-23.
2005: Wiebke Hansen; Carsten Saft; Jürgen Andrich; Thomas Müller; Stefan Wieczorek; Jörg T Epplen; Larissa Arning
Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
Journal of negative results in biomedicine 2005;4():12.
2004: Kerstin Hellwig; Franz Josef Stein; Horst Przuntek; Thomas Müller
Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.
BMC neurology 2004;4(1):18.
2004: Thomas Müller; Horst Przuntek; Rejko Krüger; A Mackowiak
Antiapoptotic effects of budipine.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1365-73.
2004: Robert Hering; Karsten M Strauss; Xiao Tao; Andreas Bauer; Dirk Woitalla; Eva-Maria Mietz; Slobodanka Petrovic; Peter Bauer; Wilhelm Schaible; Thomas Müller; Ludger Schöls; Christine Klein; Daniela Berg; Philipp T Meyer; Jörg B Schulz; Bernd Wollnik; Liang Tong; Rejko Krüger; Olaf Riess
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).
Human mutation 2004;24(4):321-9.
2004: Thomas Müller; Harald Hefter; Roland Hueber; Wolfgang H Jost; Klaus L Leenders; Per Odin; Johannes Schwarz
Is levodopa toxic?
Journal of neurology 2004;251 Suppl 6():VI/44-6.
2004: Thomas Müller; Marcus Mannel; Harald Murck; Volker W Rahlfs
Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
Psychosomatic medicine 2004;66(4):538-47.
2004: Siegfried Muhlack; Dirk Woitalla; Jacub Welnic; Svenja Twiehaus; Horst Przuntek; Thomas Müller
Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
Neuroscience letters 2004;363(3):284-7.
2004: Thomas Müller; Kathrin Renger; Wilfried Kuhn
Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.
Archives of neurology 2004;61(5):657-60.
2004: Thomas Müller; Sabine Benz; Christian Börnke; Horst Przuntek
Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.
Acta neurologica Scandinavica 2004;109(5):348-54.
2004: Robert Hering; S Petrovic; E-M Mietz; Carsten Holzmann; Daniela Berg; Peter Bauer; Dirk Woitalla; Thomas Müller; Klaus Berger; Rejko Krüger; Olaf Riess
Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.
Neurology 2004;62(7):1231-2.
2004: Jürgen Andrich; Carsten Saft; Anneliese Arz; Birgit Schneider; Marcus W Agelink; Peter H Kraus; Wilfried Kuhn; Thomas Müller
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
Movement disorders : official journal of the Movement Disorder Society 2004;19(2):226-8.
2004: Horst Przuntek; Thomas Müller; Peter Riederer
Diagnostic staging of Parkinson's disease: conceptual aspects.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(2):201-16.
2004: Jürgen Andrich; Carsten Saft; Manfred Gerlach; B Schneider; A Arz; Wilfried Kuhn; Thomas Müller
Coenzyme Q10 serum levels in Huntington's disease.
Journal of neural transmission. Supplementum 2004;(68):111-6.
2004: Nils Brune; Jürgen Andrich; Martin Gencik; Carsten Saft; Thomas Müller; S Valentin; Horst Przuntek; Jörg T Epplen
Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.
Journal of neural transmission. Supplementum 2004;(68):105-10.
2004: Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller
Congruent deterioration of complex and simple movements in patients with Huntington's disease.
Journal of neural transmission. Supplementum 2004;(68):97-104.
2004: Dirk Woitalla; Thomas Müller; Sabine Benz; R Horowski; Horst Przuntek
Transdermal lisuride delivery in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 2004;(68):89-95.
2004: Thomas Müller; Sabine Benz; Christian Börnke; Siegfried Muhlack; Dirk Woitalla; Horst Przuntek
Worsened motor test performance following acute apomorphine injection in previously untreated patients with Parkinson's disease.
Journal of neural transmission. Supplementum 2004;(68):79-87.
2004: Gebhard Schmid; Boris Suchan; J Rusin; Irene Daum; Odo Köster; Horst Przuntek; Thomas Müller; Sören Peters
Impact of apomorphine on BOLD signal during movement in normals.
Journal of neural transmission. Supplementum 2004;(68):69-78.
2004: Christian Börnke; T Schulte; Horst Przuntek; Thomas Müller
Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.
Journal of neural transmission. Supplementum 2004;(68):61-7.
2004: Siegfried Muhlack; S Konietzka; Dirk Woitalla; Horst Przuntek; Thomas Müller
Simple movement sequences better correlate to levodopa plasma levels than complex ones.
Journal of neural transmission. Supplementum 2004;(68):53-60.
2004: A S Glass; duong huynh; Thomas Franck; Dirk Woitalla; Thomas Müller; Stef pulst; Daniela Berg; Rejko Krüger; Olaf Riess
Screening for mutations in synaptotagmin XI in Parkinson's disease.
Journal of neural transmission. Supplementum 2004;(68):21-8.
2004: Dirk Woitalla; Wilfried Kuhn; Thomas Müller
MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease.
Journal of neural transmission. Supplementum 2004;(68):15-20.
2004: Thomas Müller; Birgit Voss; Kerstin Hellwig; Franz Josef Stein; Thorsten Schulte; Horst Przuntek
Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.
CNS drugs 2004;18(2):105-11.
2003: Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller
Assessment of complex movements reflects dysfunction in Huntington's disease.
Journal of neurology 2003;250(12):1469-74.
2003: Rejko Krüger; Christian Fischer; Thorsten Schulte; Karsten M Strauss; Thomas Müller; Dirk Woitalla; Daniela Berg; Marcel Hungs; René Gobbele; Klaus Berger; Jörg T Epplen; Olaf Riess; Ludger Schöls
Mutation analysis of the neurofilament M gene in Parkinson's disease.
Neuroscience letters 2003;351(2):125-9.
2003: Thomas Müller; Margareta Meisel; Hermann Russ; Horst Przuntek
Motor impairment influences Farnsworth-Munsell 100 Hue test error scores in Parkinson's disease patients.
Journal of the neurological sciences 2003;213(1-2):61-5.
2003: Thomas Müller
[Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122].
Der Nervenarzt 2003;74(8):726-7.
2003: Carsten Saft; Jürgen Andrich; M Stücker; H Przuntek; Thomas Müller
Asymmetric anhidrosis in MSA.
Neurology 2003;61(2):231.
2003: Volker Hoffmann; Sebastian Schimrigk; Saida Islamova; Kerstin Hellwig; Carsten Lukas; Nils Brune; Dieter Pöhlau; Horst Przuntek; Thomas Müller
Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Journal of the neurological sciences 2003;211(1-2):81-4.
2003: T Schulte; Stefan Boehringer; Ludger Schöls; Thomas Müller; C Fischer; Olaf Riess; Horst Przuntek; K Berger; Jörg T Epplen; Rejko Krüger
Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(7):749-55.
2003: Thomas Müller; Sabine Benz; Christian Börnke; Hermann Russ; Horst Przuntek
Repeated rating improves value of diagnostic dopaminergic challenge tests in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(6):603-9.
2003: Thomas Müller; Thomas Büttner; Ali Farshad Gholipour; Wilfried Kuhn
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
Neuroscience letters 2003;341(3):201-4.
2003: Sören Peters; Boris Suchan; Joanna Rusin; Irene Daum; Odo Köster; Horst Przuntek; Thomas Müller; Gebhard Schmid
Apomorphine reduces BOLD signal in fMRI during voluntary movement in Parkinsonian patients.
Neuroreport 2003;14(6):809-12.
2003: Thomas Müller; Jürgen Fritze
Fibrosis associated with dopamine agonist therapy in Parkinson's disease.
Clinical neuropharmacology 2003;26(3):109-11.
2003: Jennifer Uekermann; Irene Daum; Sören Peters; Burkhard Wiebel; Horst Przuntek; Thomas Müller
Depressed mood and executive dysfunction in early Parkinson's disease.
Acta neurologica Scandinavica 2003;107(5):341-8.
2003: Thomas Müller; D Woitalla; W Kuhn
Benefit of folic acid supplementation in parkinsonian patients treated with levodopa.
Journal of neurology, neurosurgery, and psychiatry 2003;74(4):549.
2003: Thomas Müller; Wilfried Kuhn; Thorsten Schulte; Horst Przuntek
Intravenous amantadine sulphate application improves the performance of complex but not simple motor tasks in patients with Parkinson's disease.
Neuroscience letters 2003;339(1):25-8.
2003: Thomas Müller; Birgit Voss; Kerstin Hellwig; Horst Przuntek
Treatment benefit correlates with increase of daily drug costs in Parkinson's disease clinics.
NeuroRehabilitation 2003;18(3):271-5.
2003: Thomas Müller; Horst Przuntek; Anita Kuhlmann
Loss of color vision during long-term treatment with pramipexole.
Journal of neurology 2003;250(1):101-2.
2002: Thomas Müller
CPI-1189. Centaur.
Current opinion in investigational drugs (London, England : 2000) 2002;3(12):1763-7.
2002: Jens Reimer; Anita Kuhlmann; Thomas Müller
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide.
Parkinsonism & related disorders 2002;9(2):115-6.
2002: Peter Riederer; Gabriele Gille; Thomas Müller; Horst Przuntek; Heinz Reichmann; Olaf Riess; A Schwartz; Johannes Schwarz; T Vogt
Practical importance of neuroprotection in Parkinson's disease.
Journal of neurology 2002;249 Suppl 3():III/53-6.
2002: Thomas Müller
Dopaminergic substitution in Parkinson's disease.
Expert opinion on pharmacotherapy 2002;3(10):1393-403.
2002: Thorsten Schulte; Ludger Schöls; Thomas Müller; Dirk Woitalla; Klaus Berger; Rejko Krüger
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease.
Neuroscience letters 2002;326(1):70-2.
2002: Thomas Müller; Sabine Benz; Horst Przuntek
Apomorphine delays simple reaction time in Parkinsonian patients.
Parkinsonism & related disorders 2002;8(5):357-60.
2002: Horst Przuntek; Stefan Bittkau; Harald Bliesath; Ulrich Büttner; Gerd Fuchs; Joachim Glass; Harald Haller; Thomas Klockgether; Peter H Kraus; Lutz Lachenmayer; Dieter Müller; Thomas Müller; Bernhard Rathay; Jörg Sgonina; Volker Steinijans; Elemer Teshmar; Gudrun Ulm; Dieter Volc
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Archives of neurology 2002;59(5):803-6.
2002: Thomas Müller; Dirk Woitalla; Sören Peters; K Kohla; Horst Przuntek
Progress of visual dysfunction in Parkinson's disease.
Acta neurologica Scandinavica 2002;105(4):256-60.
2002: Thomas Müller
Drug treatment of non-motor symptoms in Parkinson's disease.
Expert opinion on pharmacotherapy 2002;3(4):381-8.
2002: Thomas Müller; Dirk Woitalla; B Fowler; Wilfried Kuhn
3-OMD and homocysteine plasma levels in parkinsonian patients.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(2):175-9.
2002: Thomas Müller; Sabiene Benz; Horst Przuntek
Tapping and peg insertion after levodopa intake in treated and de novo parkinsonian patients.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2002;29(1):73-7.
2002: Thomas Müller; Sabine Benz
Quantification of the dopaminergic response in Parkinson's disease.
Parkinsonism & related disorders 2002;8(3):181-6.
2001: Thomas Müller; Sabine Benz; Christian Börnke
Delay of simple reaction time after levodopa intake.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(11):2133-7.
2001: Rejko Krüger; Ludger Schöls; Thomas Müller; Wilfried Kuhn; Dirk Woitalla; Horst Przuntek; Jörg T Epplen; Olaf Riess
Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
Neuroscience letters 2001;310(2-3):191-3.
2001: Alexander Zimprich; Monika Grabowski; Friedrich Asmus; M Naumann; Daniela Berg; M Bertram; K Scheidtmann; P Kern; Juliane Winkelmann; Bertram Müller-Myhsok; L Riedel; M Bauer; Thomas Müller; Mirna Castro; Thomas Meitinger; Tim M Strom; Thomas Gasser
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.
Nature genetics 2001;29(1):66-9.
2001: Thomas Müller; Dirk Woitalla; B Hauptmann; B Fowler; Wilfried Kuhn
Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease.
Neuroscience letters 2001;308(1):54-6.
2001: Rejko Krüger; Wilfried Kuhn; Klaus L Leenders; Reiner Sprengelmeyer; Thomas Müller; Dirk Woitalla; Axel T Portman; R P Maguire; L Veenma; U Schröder; Ludger Schöls; Jörg T Epplen; Olaf Riess; Horst Przuntek
Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers.
Neurology 2001;56(10):1355-62.
2001: S Peters; Ernst G Eising; Horst Przuntek; Thomas Müller
Vascular Parkinsonism: a case report and review of the literature.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2001;8(3):268-71.
2001: Thomas Müller
Non-dopaminergic drug treatment of Parkinson's disease.
Expert opinion on pharmacotherapy 2001;2(4):557-72.
2001: Peter Haussermann; W Kuhn; H Przuntek; Thomas Müller
Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.
Neuroscience letters 2001;300(3):182-4.
2001: Ernst G Eising; Thomas Müller; Lutz S Freudenberg; Stefan P Müller; K Dutschka; W Sonnenschein; Horst Przuntek; Andreas Bockisch
SPECT imaging with [123I]-beta-CIT in Parkinsonism: comparison of SPECT images obtained by a single-headed and a three-headed gamma camera.
Nuclear medicine communications 2001;22(2):145-50.
2001: W Kuhn; T Hummel; D Woitalla; Thomas Müller
Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
Neurology 2001;56(2):281; author reply 281-2.
2000: Thomas Müller; S Benz; Horst Przuntek
Choice reaction time after levodopa challenge in parkinsonian patients.
Journal of the neurological sciences 2000;181(1-2):98-103.
2000: Thomas Müller; S Schäfer; Wilfried Kuhn; Horst Przuntek
Correlation between tapping and inserting of pegs in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2000;27(4):311-5.
2000: Heinz Reichmann; U Sommer; G Fuchs; H Hefter; G Mark; Thomas Müller; R Thümler; G Ulm; Peter Vieregge
Workshop IV: drug treatment guidelines for the long-term management of Parkinson's disease.
Journal of neurology 2000;247 Suppl 4():IV/40-1.
2000: Peter Riederer; Thomas Brücke; C Buhmann; Thomas Müller; A Schwartz; A Storch; Beate Winner
Workshop II: "neuroprotection"--the Lugano consensus.
Journal of neurology 2000;247 Suppl 4():IV/36-7.
2000: Rejko Krüger; AM Menezes Saecker; Ludger Schöls; Wilfried Kuhn; Thomas Müller; Dirk Woitalla; Daniela Berg; K Berger; Horst Przuntek; Jörg T Epplen; Olaf Riess
Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease.
Neuroreport 2000;11(11):2439-42.
2000: P Wintermeyer; Rejko Krüger; Wilfried Kuhn; Thomas Müller; Dirk Woitalla; Daniela Berg; G Becker; E Leroy; Mihael H Polymeropoulos; K Berger; Horst Przuntek; Ludger Schöls; Jörg T Epplen; Olaf Riess
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.
Neuroreport 2000;11(10):2079-82.
2000: Thomas Müller; Dirk Woitalla; A Hunsdiek; Wilfried Kuhn
Elevated plasma levels of homocysteine in dystonia.
Acta neurologica Scandinavica 2000;101(6):388-90.
2000: Rejko Krüger; Cornelia Hardt; F Tschentscher; S Jäckel; W Kuhn; Thomas Müller; J Werner; Dirk Woitalla; Daniela Berg; N Kühnl; G A Fuchs; Eduardo J M Santos; Horst Przuntek; Jörg T Epplen; Ludger Schöls; Olaf Riess
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(5):553-62.
2000: A Rahbar; M Kempkes; Thomas Müller; S Reich; FL Welter; Saskia Meves; Horst Przuntek; H M Bolt; Wilfried Kuhn
Glutathione S-transferase polymorphism in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(3):331-4.
2000: Thomas Müller; Dirk Woitalla; D Schulz; S Peters; Wilfried Kuhn; Horst Przuntek
Tolcapone increases maximum concentration of levodopa.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):113-9.
2000: Dirk Woitalla; R Karwasz; Thomas Müller; Horst Przuntek; Wilfried Kuhn
The activity of catechol-O-methyltransferase in parkinsonian patients with "on-off fluctuations".
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):105-11.
2000: T h Büttner; Thomas Müller; Wilfried Kuhn
Effects of apomorphine on visual functions in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):87-94.
2000: Rejko Krüger; Thomas Müller; Olaf Riess
Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):31-40.
1999: Hermann Russ; Thomas Müller; Dirk Woitalla; A Rahbar; J Hahn; W Kuhn
Detection of tolcapone in the cerebrospinal fluid of parkinsonian subjects.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(6):719-20.
1999: Thomas Müller; Wilfried Kuhn; T h Büttner; Horst Przuntek
Colour vision abnormalities and movement time in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(6):711-5.
1999: Thomas Müller; Ernst G Eising; Wilfried Kuhn; T h Büttner; HH Coenen; Horst Przuntek
Delayed motor response correlates with striatal degeneration in Parkinson's disease.
Acta neurologica Scandinavica 1999;100(4):227-30.
1999: Thomas Müller; B Werne; B Fowler; W Kuhn
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease.
Lancet 1999;354(9173):126-7.
1999: T h Büttner; B Lack; M Jäger; W Wünsche; Wilfried Kuhn; Thomas Müller; Horst Przuntek; Thomas Postert
Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures.
Journal of neurology 1999;246(6):459-61.
1999: Thomas Müller; Horst Przuntek; Wilfried Kuhn; S S Baum; Hans Rommelspacher
No increase of synthesis of (R)salsolinol in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):514-5.
1999: Rejko Krüger; AM Vieira-Saecker; Wilfried Kuhn; Daniela Berg; Thomas Müller; N Kühnl; G A Fuchs; A Storch; Marcel Hungs; Dirk Woitalla; Horst Przuntek; Jörg T Epplen; Ludger Schöls; Olaf Riess
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.
Annals of neurology 1999;45(5):611-7.
1999: Thomas Müller; S Sällström Baum; P Häussermann; Horst Przuntek; Hans Rommelspacher; Wilfried Kuhn
R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients.
Journal of the neurological sciences 1999;164(2):158-62.
1999: Thomas Müller; Georgios Amoiridis; Wilfried Kuhn; Horst Przuntek
Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
European neurology 1999;42(4):240-1.
1999: Horst Przuntek; Thomas Müller
Clinical efficacy of budipine in Parkinson's disease.
Journal of neural transmission. Supplementum 1999;56():75-82.
1999: Rejko Krüger; A M Vieira-Säcker; Wilfried Kuhn; Thomas Müller; Dirk Woitalla; Ludger Schöls; Horst Przuntek; Jörg T Epplen; Olaf Riess
Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(2):159-63.
1999: T h Büttner; Wilfried Kuhn; M Dietz; Thomas Müller; Thomas Postert; Horst Przuntek; FL Welter
Impaired visual function in focal idiopathic dystonia.
European neurology 1999;41(2):94-8.
1998: W Kuhn; R Roebroek; H Blom; D van Oppenraaij; Thomas Müller
Hyperhomocysteinaemia in Parkinson's disease.
Journal of neurology 1998;245(12):811-2.
1998: Wilfried Kuhn; R Roebroek; H Blom; D van Oppenraaij; Horst Przuntek; A Kretschmer; T h Büttner; Dirk Woitalla; Thomas Müller
Elevated plasma levels of homocysteine in Parkinson's disease.
European neurology 1998;40(4):225-7.
1998: W Kuhn; Dirk Woitalla; Manfred Gerlach; Hermann Russ; Thomas Müller
Tolcapone and neurotoxicity in Parkinson's disease.
Lancet 1998;352(9136):1313-4.
1998: Thomas Müller; Wilfried Kuhn; T h Büttner; Ernst G Eising; HH Coenen; M Haas; Horst Przuntek
Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease.
Journal of neurology 1998;245(10):659-64.
1998: J Federlein; Thomas Postert; Horst Przuntek; Thomas Müller
Central pontine myelinolysis causes bilateral loss of deep sensitivity and pseudochoreoathetosis.
Journal of neurology, neurosurgery, and psychiatry 1998;65(4):607-8.
1998: T h Büttner; Thomas Müller; Kerstin Hellwig; Saskia Meves; W Kuhn
Antipyretic therapy in acute stroke.
Lancet 1998;352(9129):740.
1998: Thomas Müller; D Blum-Degen; Horst Przuntek; Wilfried Kuhn
Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease.
Acta neurologica Scandinavica 1998;98(2):142-4.
1998: Wilfried Kuhn; Thomas Müller; A Gerstner; R Winkel; M E Goetz
Platelet monoamine oxidase B activity in "de novo" and l-dopa treated parkinsonian patients and controls.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1998;25(3):249-51.
1998: Wilfried Kuhn; R Winkel; Dirk Woitalla; Saskia Meves; Horst Przuntek; Thomas Müller
High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries.
Neurology 1998;50(6):1885-6.
1998: Thomas Müller; Wilfried Kuhn; Christian Börnke; T h Büttner; Horst Przuntek
Kleine-Levin syndrome and Parkinsonian symptoms--a case report.
Journal of the neurological sciences 1998;157(2):214-6.
1998: R Krüger; W Kuhn; Thomas Müller; D Woitalla; Manuel B Graeber; Siegfried Kösel; H Przuntek; J T Epplen; L Schöls; Olaf Riess
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
Nature genetics 1998;18(2):106-8.
1998: Thomas Müller; S Sällström Baum; P Häussermann; Dirk Woitalla; Hans Rommelspacher; Horst Przuntek; Wilfried Kuhn
Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(2-3):239-46.
1998: T h Büttner; Kerstin Hellwig; Thomas Müller; Wilfried Kuhn
Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
Clinical neuropharmacology 1998;21(1):48-51.
1998: Thomas Müller; Wilfried Kuhn; Rejko Krüger; Horst Przuntek
Selegiline as immunostimulant--a novel mechanism of action?
Journal of neural transmission. Supplementum 1998;52():321-8.
1998: Thomas Müller; J Farahati; Wilfried Kuhn; Ernst G Eising; Horst Przuntek; Christoph Reiners; HH Coenen
[123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients.
European neurology 1998;39(1):44-8.
1997: Thomas Müller; Ernst G Eising; Christoph Reiners; Horst Przuntek; M Jacob; Wilfried Kuhn
2-[123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian patients: is it a marker of striatal pre-synaptic degeneration?
Nuclear medicine communications 1997;18(12):1115-21.
1997: Thomas Müller; Wilfried Kuhn; T h Büttner; Horst Przuntek
Distorted colour discrimination in Parkinson's disease is related to severity of the disease.
Acta neurologica Scandinavica 1997;96(5):293-6.
1997: Ernst G Eising; Thomas Müller; C Zander; Wilfried Kuhn; J Farahati; Christoph Reiners; HH Coenen
SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1997;45(8):448-52.
1997: W Kuhn; Thomas Müller
[Therapy of Parkinson disease. 2: New therapy concepts for treating motor symptoms].
Fortschritte der Neurologie-Psychiatrie 1997;65(8):375-85.
1997: W Kuhn; Thomas Müller
[Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].
Fortschritte der Neurologie-Psychiatrie 1997;65(8):361-74.
1997: Thomas Müller; W Kuhn; Horst Przuntek
[Non-motor symptoms of Parkinson disease. Significant impact on quality of life--using possible treatments].
Fortschritte der Medizin 1997;115(14):45-8.
1997: Thomas Müller; W Kuhn; Horst Przuntek
[Current therapy of idiopathic Parkinson disease. 2: Recent and alternative therapies].
Fortschritte der Medizin 1997;115(13):37-41.
1997: Thomas Müller; W Kuhn; Horst Przuntek
[Current therapy of idiopathic Parkinson disease. 1: Diagnosis, therapeutic guidelines, standard pharmacotherapy and physical therapy].
Fortschritte der Medizin 1997;115(13):28, 31-4.
1997: W Kuhn; Thomas Müller; I Nastos; D Poehlau
The neuroimmune hypothesis in Parkinson's disease.
Reviews in the neurosciences 1997;8(1):29-34.
1996: K Wilfried; Thomas Müller; Rejko Krüger; P Horst
Selegiline stimulates biosynthesis of cytokines interleukin-1 beta and interleukin-6.
Neuroreport 1996;7(18):2847-8.
1996: T Büttner; W Kuhn; Thomas Müller; T Heinze; C Pühl; H Przuntek
Chromatic and achromatic visual evoked potentials in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1996;100(5):443-7.
1996: Wilfried Kuhn; Thomas Müller; T h Büttner; M Gerlach
Antioxidative properties of aspirin: dose dependence and clinical implications.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1996;3(3):275-7.
1996: Wilfried Kuhn; Thomas Müller; Manfred Gerlach; Emin Sofic; G Fuchs; N Heye; R Prautsch; Horst Przuntek
Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(12):1441-5.
1996: Wilfried Kuhn; Thomas Müller; H Grosse; H Rommelspacher
Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(12):1435-40.
1996: T h Büttner; Wilfried Kuhn; Thomas Müller; F L Welter; J Federlein; K Heidbrink; Horst Przuntek
Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(10):1195-204.
1996: Wilfried Kuhn; Thomas Müller; R Winkel; S Danielczik; A Gerstner; R Häcker; Claudia Mattern; Horst Przuntek
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(10):1187-93.
1996: Wilfried Kuhn; Thomas Müller
The clinical potential of Deprenyl in neurologic and psychiatric disorders.
Journal of neural transmission. Supplementum 1996;48():85-93.
1996: Manfred Gerlach; Wilfried Kuhn; Thomas Müller; P Klotz; Horst Przuntek
Sustained-release of levodopa: single dose study of a new formulation.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(6):717-27.
1996: Wilfried Kuhn; N Heye; Thomas Müller; P Kraus; P Klotz; B Friedrich; F L Welter; Horst Przuntek
The motor performance test series in Parkinson's disease is influenced by depression.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(3):349-54.
1995: D Blum-Degen; Thomas Müller; W Kuhn; Manfred Gerlach; Horst Przuntek; Peter Riederer
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
Neuroscience letters 1995;202(1-2):17-20.
1995: Philippa Hulley; Jukka Hartikka; S Abdel'Al; P Engels; H R Buerki; Karl-Heinz Wiederhold; Thomas Müller; P Kelly; D Lowe; Hermann Lübbert
Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo.
The European journal of neuroscience 1995;7(12):2431-40.
1995: Wilfried Kuhn; Thomas Müller; H Grosse; T Dierks; H Rommelspacher
Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease.
Acta neurologica Scandinavica 1995;92(6):451-4.
1995: W Kuhn; Thomas Müller; T h Büttner; Manfred Gerlach
[Acetylsalicylic acid as free radical scavenger. An argument for increased dosages in acute and preventive therapy of vascular diseases].
Fortschritte der Medizin 1995;113(33):483-4.
1995: T h Büttner; Wilfried Kuhn; Thomas Müller; Tanja Patzold; Horst Przuntek
Color vision in Parkinson's disease: missing influence of amantadine sulphate.
Clinical neuropharmacology 1995;18(5):458-63.
1995: W Kuhn; Thomas Müller; T Bttner; Manfred Gerlach
Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia.
Stroke; a journal of cerebral circulation 1995;26(10):1959-60.
1995: Thomas Müller; T h Büttner; Wilfried Kuhn; A Heinz; Horst Przuntek
Palinopsia as sensory epileptic phenomenon.
Acta neurologica Scandinavica 1995;91(6):433-6.
1995: Thomas Müller; W Kuhn; D Pöhlau; H Przuntek
Parkinsonism unmasked by lovastatin.
Annals of neurology 1995;37(5):685-6.
1995: T h Büttner; Wilfried Kuhn; Thomas Müller; Tanja Patzold; K Heidbrink; Horst Przuntek
Distorted color discrimination in 'de novo' parkinsonian patients.
Neurology 1995;45(2):386-7.
1995: Thomas Müller; Wilfried Kuhn; G Quack; Horst Przuntek
Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients.
Journal of neural transmission. Supplementum 1995;46():407-13.
1995: Wilfried Kuhn; Thomas Müller; H Grosse; H Rommelspacher
Plasma harman and norharman in Parkinson's disease.
Journal of neural transmission. Supplementum 1995;46():291-5.
1995: Wilfried Kuhn; Thomas Müller
Neuroimmune mechanisms in Parkinson's disease.
Journal of neural transmission. Supplementum 1995;46():229-33.
1995: Wilfried Kuhn; Thomas Müller
Exogenous stimulation of NGF synthesis by catecholamines and their analogues.
Journal of neural transmission. Supplementum 1995;46():189-92.
1993: Thomas Müller; Wilfried Kuhn; Horst Przuntek
Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?
Journal of neural transmission. General section 1993;92(2-3):187-95.
1991: M Gavranovic; Thomas Müller; Emin Sofic; Z Bilalbegovic
Anticonvulsants combined with nifedipine for epilepsy in adults.
The American journal of psychiatry 1991;148(6):808-9.
1990: J Fritze; Emin Sofic; Thomas Müller; H Pfüller; Mario Lanczik; Peter Riederer
Cholinergic-adrenergic balance: Part 2. Relationship between drug sensitivity and personality.
Psychiatry research 1990;34(3):271-9.
1990: J Fritze; Emin Sofic; Thomas Müller; H Pfüller; Mario Lanczik; Peter Riederer
Cholinergic-adrenergic balance: Part 1. Relationship between central and peripheral sensitivities.
Psychiatry research 1990;34(3):259-70.